Concepedia

Erika Gyzander

EG

Statistics

Publications

16

Citations

1.5K

H-Index

14

Active since

1977

Affiliations

Sahlgrenska University Hospital(Current)

AstraZeneca (Sweden)

University of Gothenburg

Erika Gyzander is an author at Sahlgrenska University Hospital specializing in medicine, hemostasis, and thrombosis.

Publications per year

1977–2009

16

Publications

16

The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects

David Gustafsson, Jan-Erik Nyström, Stefan Carlsson et al. · Thrombosis Research · 2001 · 302 citations

, , +17

Effects of Melagatran, a New Low-molecular-weight Thrombin Inhibitor, on Thrombin and Fibrinolytic Enzymes

Thomas Antonsson, Ulf G. Eriksson, Erika Gyzander et al. · Thrombosis and Haemostasis · 1998 · 209 citations

, , +17

Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate

A.‐C. Teger‐Nilsson, P. Friberger, Erika Gyzander · Scandinavian Journal of Clinical and Laboratory Investigation · 1977 · 201 citations

, , +12

Determination of a new rapid plasmin inhibitor in human blood by means of a plasmin specific tripeptide substrate

A.‐C. Teger‐Nilsson, P. Friberger, Erika Gyzander · Scandinavian Journal of Clinical and Laboratory Investigation · 1977 · 161 citations

, , +12

Biosensor Analysis of Drug–Target Interactions: Direct and Competitive Binding Assays for Investigation of Interactions between Thrombin and Thrombin Inhibitors

Robert Karlsson, Mari Kullman-Magnusson, Markku Hämäläinen et al. · Analytical Biochemistry · 2000 · 126 citations

, , +17

1–5 of 16